Prior to Elanco’s Canine Parvovirus Monoclonal Antibody, the only treatment for the highly contagious canine parvovirus was supportive therapy, which can consist of 24/7 care, multi-day hospitalization and emotional stress for the staff and pet owner with no guaranteed outcome and potentially high pet owner costs. Our latest innovative product aims to change all of that.
Learn more about Elanco’s Canine Parvovirus Monoclonal Antibody: [ Ссылка ]
